News & Media
Press Center & More

Up-to-date press releases and statements in all categories, as well as materials for journalists.

Mar 6, 2023

Novavax to Participate in TD Cowen's 43rd Annual Health Care Conference

Mar 2, 2023
Corporate and finance

Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4)

Feb 28, 2023
Corporate and finance

Novavax Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights

Media contact

Images, videos, and files for media use

Extensive materials for members of the press, including broadcast, online, film, radio and print journalists.

About Novavax

Novavax, Inc. (Nasdaq: NVAX) is a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases.